Physician profile
Matthew L Ryan
NPI 1548233612
$7,166.85
in general payments reported to CMS, 2019-2025
11 companies · $64.20 in 2025
The $64.20 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.26 · 2021: $24.80 · 2022: $37.92 · 2023: $3,137 · 2024: $3,881 · 2025: $64.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,549 · Food and Beverage: $517 · Education: $15.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,549.46 |
| Food and Beverage | $516.92 |
| Education | $15.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $6,569.46 | 2023-2024 | Hemgenix, Idelvion, Afstyla |
| Biomarin Pharmaceutical INC. | $238.28 | 2023-2024 | Roctavian |
| Genzyme Corporation | $215.16 | 2023-2025 | |
| Conmed Corporation | $43.48 | 2023 | Airseal |
| E.R. Squibb & Sons, L.L.C. | $22.33 | 2022 | |
| Getinge USA Sales, LLC | $22.26 | 2019 | |
| Pfizer INC. | $15.59 | 2022 | |
| Amgen INC. | $15.49 | 2023 | |
| Acrotech Biopharma INC. | $13.93 | 2021 | |
| Merck Sharp & Dohme LLC | $10.87 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.